Catalogue Number: PAX008-0.5-EXA
| Manufacturer: | ExAlpha |
| Type: | Monoclonal Primary Antibody - Unconjugated |
| Alias: | Paired box protein 8 |
| Shipping Condition: | RT |
| Storage Condition: | 2-8°C |
| Unit(s): | 0.5 ml |
| Host name: | Rabbit |
| Clone: | ZR1 |
| Isotype: | IgG |
| Immunogen: | |
| Application: | IHC-P, IHC-Fr |
Description: PAX-8 is expressed in the thyroid, non-ciliated mucosal cells of the fallopian tubes and simple ovarian inclusion cysts, but not normal ovarian surface epithelial cells. The antibody against PAX-8 is well suited for the detection of the protein in ovarian clear cell carcinoma. The cellular localization is nuclear. PAX-8 is expressed in the thyroid (and associated carcinomas), non-ciliated mucosal cells of the fallopian tubes and simple ovarian inclusion cysts, but not normal ovarian surface epithelial cells. PAX-8 is expressed in a high percentage of ovarian serous, endometroid, and clear cell carcinomas, but only rarely in primary ovarian mucinous adenocarcinomas. Studies have also found PAX-8 expression in renal tubules as well as renal carcinoma, nephroblastoma and seminoma. Over 98% of clear cell RCCs, 90% of papillary RCCs, and 95% of oncocytomas were positive for PAX-8, frequencies which are similar or better than for PAX-2. Normal lung and lung carcinomas do not express PAX-8. Similarly, the absence of expression of PAX-8 in breast and other non-GYN carcinomas other than those primary to the thyroid indicates that PAX-8 is an important new marker of ovarian cancer and a useful marker for the differential diagnoses in lung and neck tumors, or tumors at distant sites where primary lung carcinoma or thyroid carcinoma are possibilities. PAX-8, combined with organ system-specific markers such as uroplakin, mammaglobin, and TTF-1 can be a very useful panel to differentiate the primary site of invasive micro-papillary carcinomas of ovary from those of the bladder, lung, and breast. The ZR1 antibody does not react with pancreatic neuroendocrine tumors, thymic tumors, and lymphocytes.
7849
PAX8
Q06710
Monoclonal
2-8°C
IHC (C,P) Staining procedures: Use formalin-fixed and paraffin-embedded sections. Retrieval conditions: Pretreatment of deparaffinized tissue with heat-induced epitope retrieval (EDTA, pH9.0) is recommended. Detection methods: Polymer anti-mouse/rabbit Ig detection system. Working dilution: 1:50-100; Positive Control: Ovarian serous carcinoma. Cellular Localization: Nuclear.